REVERSED
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2865 Ex Parte Brusniak 12164882 - (D) ABRAHAM 103 Patterson & Sheridan - The Boeing Company PARK, HYUN D
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3742 Ex Parte Li et al 12201167 - (D) BAHR 102/103 GENERAL ELECTRIC COMPANY ROSS, DANA
AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1629 Ex Parte Bernstein 13197581 - (D) POLLOCK 103 103 Barnes & Thornburg LLP (CH) DRAPER, LESLIE A ROYDS
In order to establish a prima facie case of obviousness, the Examiner must show that each and every limitation of the claim is described or suggested by the combination of prior art references or would have been obvious based on the knowledge of those of ordinary skill in the art. In re Fine, 837 F.2d 1071, 1074 (Fed. Cir. 1988). Because the Examiner has not shown that Kroger, or any of the art of record, teaches or suggests the use of folic acid, we reverse the rejection of claims 34-36.
Fine, In re, 837 F.2d 1071, 5 USPQ2d 1596 (Fed. Cir. 1988) 707.07(f) , 2143.01 , 2143.03 , 2144
Tech Center 1700 Chemical & Materials Engineering
1716 Ex Parte Gero et al 12723405 - (D) HASTINGS 103 103 Kinney & Lange, P.A. CHEN, KEATH T
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3652 Ex Parte Olivier 13121154 - (D) STEPINA 102/103 102/103 41.50 103 GARVEY SMITH NEHRBASS & NORTH, LLC BERRY JR, WILLIE WENDELL
AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1631 Ex Parte Leuthardt et al 12459029 - (D) McGRAW 112(2)/102/103 Constellation Law Group, PLLC HARWARD, SOREN T
1657 Ex Parte Chan et al 11869657 - (D) POLLOCK 103 Quest Diagnostics SINGH, SATYENDRA K
1674 Ex Parte Barber 12175898 - (D) FREDMAN 102 103 MARSHALL, GERSTEIN & BORUN LLP WHITEMAN, BRIAN A
Tech Center 1700 Chemical & Materials Engineering
1765 Ex Parte Charati et al 11689228 - (D) COLAIANNI 103 CANTOR COLBURN LLP VALDEZ, DEVE E
1791 Ex Parte Kragh et al 11412797 - (D) BEST 103 DuPont Nutrition Biosciences APS GWARTNEY, ELIZABETH A
Tech Center 2100 Computer Architecture and Software
2142 Ex Parte Bimbra et al 11936230 - (D) KRIVAK 103 Patterson & Sheridan, LLP ABDUL-ALI, OMAR R
2185 Ex Parte Daga et al 12235471 - (D) DANG 112(2) 102/103 Polsinelli PC ORACLE AMERICA, INC. ZAMAN, FAISAL M
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2432 Ex Parte Salowey 11034346 - (D) DROESCH 103 HICKMAN PALERMO BECKER BINGHAM LLP DINH, MINH
2486 Ex Parte Klein Gunnewiek et al 12517224 - (D) STRAUSS 102/103 PHILIPS INTELLECTUAL PROPERTY & STANDARDS MUNG, ON S
Tech Center 2600 Communications
2611 Ex Parte Pimmel 11929332 - (D) KRIVAK 112(2)/103 Kilpatrick Townsend & Stockton LLP Adobe Systems, Inc. 58083 SAMS, MICHELLE L
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3626 Ex Parte Gravina 12392968 - (D) BAYAT 103 Tillman Wright, PLLC BURGESS, JOSEPH D
Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3717 Ex Parte CHANDHOK et al 11757373 - (D) KERINS 103/double patenting 41.50 103 QUALCOMM INCORPORATED GALKA, LAWRENCE STEFAN
3747 Ex Parte Liebsch et al 12516916 - (D) WIEKER 102 Novak Druce Connolly Bove + Quigg LLP TRAN, LONG T
3752 Ex Parte GRANDPIERRE 12620793 - (D) HOSKINS 103 LOWE HAUPTMAN & HAM, LLP LE, VIET
3754 Ex Parte Doneghue et al 11380568 - (D) SMEGAL 103 Barnes & Thornburg LLP (CH) JACYNA, J CASIMER
3777 Ex Parte Kucharczyk et al 12321139 - (D) POLLOCK 102/103 101 Mark A. Litman & Associates, P.A. ROY, BAISAKHI
The Board finds no evidence that a terminal disclaimer has been filed in either application. More to the point, a statutory double patenting rejection under 35 U.S.C. § 101 cannot be cured by terminal disclaimer. See In re Vogel, 422 F.2d 438, 441 (CCPA 1970).
Vogel, In re, 422 F.2d 438, 164 USPQ 619 (CCPA 1970) 804 , 804.01 , 804.02 , 1504.06
3788 Ex Parte Fallat et al 13056873 - (D) WOODS 103 COLGATE-PALMOLIVE COMPANY VAN BUSKIRK, JAMES M
REEXAMINATION
DENIED
Tech Center 1700 Chemical & Materials Engineering
1781 Ex parte VIRUN, INC. Appellant Ex Parte 8282977 et al 12/383,244 90012700 - (D) GARRIS 103 Dentons US LLP Third Party Requester Hansra Intellectual Property Law DIAMOND, ALAN D original PADEN, CAROLYN A
